Machine Learning CT-Based Automatic Nodal Segmentation and PET Semi-Quantification of Intraoperative
68Ga-PSMA-11
PET/CT
PET/CT specimen images
automatic segmentation
machine learning
prostate cancer
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
21 Sep 2023
21 Sep 2023
Historique:
received:
11
07
2023
revised:
16
09
2023
accepted:
18
09
2023
medline:
28
9
2023
pubmed:
28
9
2023
entrez:
28
9
2023
Statut:
epublish
Résumé
High-resolution intraoperative PET/CT specimen imaging, coupled with prostate-specific membrane antigen (PSMA) molecular targeting, holds great potential for the rapid ex vivo identification of disease localizations in high-risk prostate cancer patients undergoing surgery. However, the accurate analysis of radiotracer uptake would require time-consuming manual volumetric segmentation of 3D images. The aim of this study was to test the feasibility of using machine learning to perform automatic nodal segmentation of intraoperative
Identifiants
pubmed: 37761380
pii: diagnostics13183013
doi: 10.3390/diagnostics13183013
pmc: PMC10529304
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Lancet. 2020 Apr 11;395(10231):1208-1216
pubmed: 32209449
Urology. 2023 Sep 3;:
pubmed: 37669707
Eur J Nucl Med Mol Imaging. 2022 Jul;49(9):3257-3268
pubmed: 35217883
BMC Cancer. 2021 May 7;21(1):512
pubmed: 33962579
Med Image Anal. 2018 Feb;44:177-195
pubmed: 29268169
Biomedicines. 2023 Feb 20;11(2):
pubmed: 36831181
J Digit Imaging. 2023 Aug;36(4):1864-1876
pubmed: 37059891
Curr Med Imaging. 2023;19(8):832-843
pubmed: 36703586
Eur J Hybrid Imaging. 2020 Dec 9;4(1):24
pubmed: 34191197
J Digit Imaging. 2020 Aug;33(4):888-894
pubmed: 32378059
Clin Cancer Res. 2021 Jul 1;27(13):3674-3682
pubmed: 33622706
Eur J Nucl Med Mol Imaging. 2021 May;48(5):1362-1370
pubmed: 33097974
Eur J Nucl Med Mol Imaging. 2016 Jul;43(8):1477-85
pubmed: 26896298
Int J Comput Assist Radiol Surg. 2023 Jun 12;:
pubmed: 37306856
Med Phys. 2019 Feb;46(2):665-678
pubmed: 30506687
Eur J Nucl Med Mol Imaging. 2018 Apr;45(4):630-641
pubmed: 29177871
JAMA Oncol. 2021 Nov 01;7(11):1635-1642
pubmed: 34529005
J Urol. 2016 May;195(5):1436-1443
pubmed: 26682756
J Nucl Med. 2015 Aug;56(8):1185-90
pubmed: 26112024
Phys Med Biol. 2021 Mar 04;66(6):065012
pubmed: 33666176
Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):509-520
pubmed: 32789599
J Nucl Med. 2022 Dec;63(12):1941-1948
pubmed: 35772962
Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):864-877
pubmed: 30535746
Nucl Med Mol Imaging. 2023 Apr;57(2):86-93
pubmed: 36998591
Diagnostics (Basel). 2022 May 24;12(6):
pubmed: 35741119
Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3444-3456
pubmed: 33772335
J Nucl Med. 2020 Dec;61(12):1793-1799
pubmed: 32358094
J Urol. 2019 Dec;202(6):1174-1181
pubmed: 31233369
Eur Urol. 2021 Dec;80(6):682-689
pubmed: 34465492
JAMA Oncol. 2019 Jun 01;5(6):856-863
pubmed: 30920593
Lancet Oncol. 2019 Sep;20(9):1286-1294
pubmed: 31375469
Pharmaceuticals (Basel). 2014 Jun 30;7(7):779-96
pubmed: 24983957
Eur Urol Open Sci. 2023 Jun 15;54:28-32
pubmed: 37361199
Front Med (Lausanne). 2023 Feb 23;10:1133269
pubmed: 36910493
J Urol. 2021 Jul;206(1):52-61
pubmed: 33634707
Comput Biol Med. 2023 May;158:106882
pubmed: 37037147
Acta Chir Belg. 2020 Oct;120(5):366-374
pubmed: 32452298
Eur J Nucl Med Mol Imaging. 2023 Apr;50(5):1466-1486
pubmed: 36604326
Eur J Nucl Med Mol Imaging. 2020 Nov;47(12):2804-2815
pubmed: 32314028
J Clin Med. 2021 Aug 22;10(16):
pubmed: 34442033